Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Coated Fistula Plug for Post-surgical Fistulas
NCT02807389Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2017
- Primary completion
- Apr 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in gastrointestinal fistula (GIF), sponsored by Mayo Clinic. Primary endpoint: Treatment-Emergent Adverse Events at 18 months. Started Mar 2017; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
gastrointestinal fistula (GIF)
Beyond the preview
Go deeper on NCT02807389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807389.